Abscess formation mimicking disease progression, in a patient with metastatic renal cell carcinoma during sunitinib treatment

BACKGROUND: Renal cell carcinoma (RCC) represents approximately 3% of all adult cancers and is more common in males. Systemic treatment for RCC has improved following the introduction of tyrosine kinase inhibitors, such as sunitinib. The molecular targets of sunitinib are receptor tyrosine kinases (...

Descripción completa

Detalles Bibliográficos
Autores principales: Michalaki, Vasiliki, Arkadopoulos, Nikolaos, Kondi-Pafiti, Agathi, Gennatas, Constantine
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890518/
https://www.ncbi.nlm.nih.gov/pubmed/20507643
http://dx.doi.org/10.1186/1477-7819-8-45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890518/
https://www.ncbi.nlm.nih.gov/pubmed/20507643
http://dx.doi.org/10.1186/1477-7819-8-45

Ejemplares similares